ASP ISOTOPES INC (ASPI)
US00218A1051 - Common Stock
ASPI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. The financial health of ASPI is average, but there are quite some concerns on its profitability. ASPI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
ASPI had negative earnings in the past year.
ASPI had a negative operating cash flow in the past year.
1.2 Ratios
With a Return On Assets value of -49.38%, ASPI is not doing good in the industry: 94.05% of the companies in the same industry are doing better.
With a Return On Equity value of -245.59%, ASPI is not doing good in the industry: 92.86% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.38% | ||
| ROE | -245.59% | ||
| ROIC | N/A |
ROA(3y)-45.1%
ROA(5y)N/A
ROE(3y)-64.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ASPI's Gross Margin of 6.05% is on the low side compared to the rest of the industry. ASPI is outperformed by 86.90% of its industry peers.
ASPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 6.05% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
ASPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ASPI has been increased compared to 1 year ago.
ASPI has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.25 indicates that ASPI is not in any danger for bankruptcy at the moment.
ASPI has a better Altman-Z score (5.25) than 94.05% of its industry peers.
A Debt/Equity ratio of 2.70 is on the high side and indicates that ASPI has dependencies on debt financing.
ASPI's Debt to Equity ratio of 2.70 is on the low side compared to the rest of the industry. ASPI is outperformed by 89.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.7 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.25 |
ROIC/WACCN/A
WACC9.05%
2.3 Liquidity
A Current Ratio of 4.00 indicates that ASPI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.00, ASPI belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
ASPI has a Quick Ratio of 4.00. This indicates that ASPI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ASPI (4.00) is better than 94.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 4 |
3. Growth
3.1 Past
The earnings per share for ASPI have decreased strongly by -66.43% in the last year.
EPS 1Y (TTM)-66.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
Based on estimates for the next years, ASPI will show a very strong growth in Earnings Per Share. The EPS will grow by 28.56% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y47.92%
EPS Next 2Y29.9%
EPS Next 3Y28.56%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ASPI. In the last year negative earnings were reported.
Also next year ASPI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ASPI's earnings are expected to grow with 28.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.9%
EPS Next 3Y28.56%
5. Dividend
5.1 Amount
ASPI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ASP ISOTOPES INC
NASDAQ:ASPI (11/21/2024, 8:13:12 PM)
After market: 7.7 -0.01 (-0.13%)7.71
+0.56 (+7.83%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap548.64M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -49.38% | ||
| ROE | -245.59% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 6.05% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.7 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4 | ||
| Quick Ratio | 4 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-66.43%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y47.92%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y